Insmed Inc (INSM) stock: price, suppliers, customers and institutional ownership
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Insmed Inc
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Pharmaceutical Preparations
Prev close 119.91 · gapped above the open, then crossed back over prior close. High/low 122.87 at 9:30 am ET, 118.66 at 3:00 pm ET.
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1 for the treatment of patients with bronchiectasis and other neutrophil-mediated diseases; and Treprostinil Palmitil Inhalation Powder, an inhaled formulation of a treprostinil prodrug treprostinil palmitil for the treatment of pulmonary arterial hypertension and other rare pulmonary disorders. Insmed Incorporated was founded in 1988 and is headquartered in Bridgewater, New Jersey.
5 readings, 2 filed under bull and 3 under bear. Every figure is ours; the model chose the side.
the bull case· 2
+4.18%
change in shares held by the ten largest reporting managers over the latest quarter
13fJun 30 '26665
managers reporting a position in thirteen f filings
13fJun 30 '26the bear case· 3
5 of 22
of the largest reporting managers cut their stake in the latest quarter
13fJun 30 '261.08%
of State Street SPDR S&P Biotech ETF's assets the largest fund weight on file
n-portJun 30 '265
of the funds on file reporting a position in INSM
n-portas of Jun 30 '26The model filed each reading under bull or bear and wrote its caption; a caption carrying a digit is replaced by our own phrase, so every figure on this zone is ours. Built Sep 16 '26 against the Oct 30 '26 report; rebuilt when that date rolls. Not a forecast, not advice.
Insmed Inc has no measured co-movers clearing our correlation floor, so only its SEC classification is shown.
SIC 2834, Pharmaceutical Preparations, from each company's own filings. Largest first.
665 managers report a position worth $24.6B between them, and 51 of them hold 80% of it.
tall tick = annual report · 1 on record
INSM (Insmed Inc) has 18 disclosed suppliers and 2 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move, and a bundle sits past the rings until you open it. Extended: satellites hang off single companies, not bundled sectors.
Largest move on the map today: AZN −0.09%, in the industrials bundle.